Clinical Trial Update: Japanese Dose-Response Study of Rimonabant in Obese Patients [Phase 2]

View source ↗

Summary

Clinical trial update reporting completion of a Phase 2, Japanese dose‑response study of rimonabant in obese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Rimonabant (rimonabant)

Snippet

Sponsor: Sanofi | Conditions: Obesity | Phase 2 | Status: COMPLETED